BLCO (Bausch & Lomb) Float Percentage Of Total Shares Outstanding: 12.62% (As of Jul. 01, 2026)


BLCO Bausch & Lomb Corp BLCO
77 GF Score
Price $16.55
GF Value $18.33
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Bausch & Lomb Float Percentage Of Total Shares Outstanding?

Bausch & Lomb BLCO -0.06% 77 Float Percentage Of Total Shares Outstanding is 12.62% as of Jul. 01, 2026. GuruFocus rates BLCO with a GF Score™ of 77/100 and a GF Value™ of $18.33 (Fairly Valued). The stock has 9 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bausch & Lomb's float shares is 44.99 Mil. Bausch & Lomb's total shares outstanding is 356.54 Mil. Bausch & Lomb's float percentage of total shares outstanding is 12.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bausch & Lomb's Insider Ownership is 0.99%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bausch & Lomb's Institutional Ownership is 10.80%.

BLCO
77GF Score
Bausch & Lomb Corp BLCO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch & Lomb Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Bausch & Lomb's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=44.99/356.54
=12.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 12.62% mean?
Bausch & Lomb (BLCO) has a Float Percentage Of Total Shares Outstanding of 12.62% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Bausch & Lomb and its competitors.
Is Bausch & Lomb's Float Percentage Of Total Shares Outstanding too high?
Bausch & Lomb's current Float Percentage Of Total Shares Outstanding is 12.62%. Overall, Bausch & Lomb has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bausch & Lomb's Float Percentage Of Total Shares Outstanding compare to ISRG and BDX?
Bausch & Lomb's Float Percentage Of Total Shares Outstanding of 12.62% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Bausch & Lomb and its competitors. Bausch & Lomb's current Float Percentage Of Total Shares Outstanding is 12.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch & Lomb stock overvalued right now?
Based on GuruFocus' analysis, Bausch & Lomb (BLCO) is currently considered Fairly Valued. The stock's GF Value™ is $18.33, compared to a current price of $16.55 — trading 9.7% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 12.62%. Bausch & Lomb's overall GF Score™ is 77/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Bausch & Lomb (BLCO), the current Float Percentage Of Total Shares Outstanding is 12.62% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch & Lomb (BLCO) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch & Lomb stock appears to be undervalued. The current stock price of $16.55 is trading 9.7% below its estimated GF Value™ of $18.33. GuruFocus considers Bausch & Lomb to be Fairly Valued.

Key valuation signals for BLCO:

  • Float Percentage Of Total Shares Outstanding: 12.62%
  • GF Value™: $18.33 vs. price of $16.55 (9.7% below fair value)
  • GF Score™: 77/100 with 9 warning signs

No single metric tells the full story. See the BLCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch & Lomb Business Description

Other Exchanges S2L:GermanyBLCO:Canada
Address 520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
77GF Score

Get the complete analysis for BLCO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.55
Price
$18.33
GF Value